Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults | MedPage Today
WASHINGTON -- Prefusion F protein vaccine candidates for respiratory syncytial virus (RSV) proved safe in adults 60 and up while demonstrating an ability to thwart lower respiratory tract illness, including…